New purine nucleoside-based agent, which is 2,6-dichloro-9-(2,3,5-tri-O-benzoyl-beta-D-ribofuranoso-1-yl)purine, which has possessing ability to enhance the cytotoxic, DNA-damaging and antitumor effects of topotecan
2023-05-23
专利权人AS SIBE CHEM BIOLOGY & FUNDAMENTAL MEDIC (ASIC-Non-standard) ; ENGELHARDT INST MOLECULAR BIOLOGY (ENGE-Non-standard)
申请日期2023-05-23
专利号RU2023113338-A
成果简介NOVELTY - Purine nucleoside-based agent, which is 2,6-dichloro-9-[2,3,5-tri-O-benzoyl-β -D-ribofuranoso-1-yl]purine (I), is new. USE - (I) is useful for possessing ability to enhance the cytotoxic, DNA-damaging and antitumor effects of topotecan. No biological data given. ADVANTAGE - (I) has ability to enhance the cytotoxic, DNA-damaging and antitumor effects of topotecan. DETAILED DESCRIPTION - Purine nucleoside-based agent, which is 2,6-dichloro-9-[2,3,5-tri-O-benzoyl-β -D-ribofuranoso-1-yl]purine of formula (I), is new.
IPC 分类号C07D-307/20
国家俄罗斯
专业领域化学化工
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/21810
专题中国科学院新疆生态与地理研究所
作者单位
1.AS SIBE CHEM BIOLOGY & FUNDAMENTAL MEDIC (ASIC-Non-standard)
2.ENGELHARDT INST MOLECULAR BIOLOGY (ENGE-Non-standard)
推荐引用方式
GB/T 7714
CHERNYSHOVA I A,ZAKHARENKO A L,KUROCHKIN N N,et al. New purine nucleoside-based agent, which is 2,6-dichloro-9-(2,3,5-tri-O-benzoyl-beta-D-ribofuranoso-1-yl)purine, which has possessing ability to enhance the cytotoxic, DNA-damaging and antitumor effects of topotecan. RU2023113338-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。